This suggests that post-transcriptional regulation or epigenetic silencing, rather than DNA mutations, of the Hippo signaling pathway may play central roles in the aberrant inactivation of Hippo signaling and hyperactivation of YAP/TAZ transcriptional coactivators in liver cancers. Here, YAP1 is linked to liver cancer.